Correlation of DAPK1 methylation and the risk of gastrointestinal cancer: A systematic review and meta-analysis

PLoS ONE

Volumn 12, Issue 9, 2017, Pages

  Yuan, Wenzheng ^a   Chen, Jinhuang ^a   Shu, Yan ^b   Liu, Sanguang ^c   Wu, Liang ^a   Ji, Jintong ^a   Liu, Zhengyi ^a   Tang, Qiang ^a   Zhou, Zili ^a   Cheng, Yifeng ^a   Jiang, Bin ^a   Shu, Xiaogang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASIAN; CANCER PATIENT; CANCER STAGING; CARCINOGENESIS; CLINICAL FEATURE; COLORECTAL CANCER; DAPK1 GENE; DIGESTIVE SYSTEM CANCER; DNA METHYLATION; ESOPHAGUS CANCER; GENE; GENETIC ASSOCIATION; HUMAN; STOMACH CANCER; SYSTEMATIC REVIEW; TUMOR DIFFERENTIATION; GASTROINTESTINAL TUMOR; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; RISK FACTOR;

DAPK1 PROTEIN, HUMAN; DEATH ASSOCIATED PROTEIN KINASE;

DEATH-ASSOCIATED PROTEIN KINASES; DNA METHYLATION; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RISK FACTORS;

EID: 85029710842     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0184959     Document Type: Article

References (52)

1. Global Burden of Disease Cancer C, Fitzmaurice C, Dicker D, a A, Hamavid H, Moradi-Lakeh M, et al. The Global Burden of Cancer 2013. JAMA oncology. 2015 Jul; 1(4):505–27. https://doi.org/10.1001/jamaoncol.2015.0735 PMID: 26181261.
2. Jiang B, Chen JH, Yuan WZ, Ji JT, Liu ZY, Wu L, et al. Prognostic and clinical value of Sirt1 expression in gastric cancer: A systematic meta-analysis. Journal of Huazhong University of Science and Technology Medical sciences = Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban. 2016 Apr; 36(2):278–84. https://doi.org/10.1007/s11596-016-1580-0 PMID: 27072976.
3. Tahara T, Arisawa T. DNA methylation as a molecular biomarker in gastric cancer. Epigenomics. 2015 1 Jun; 7(3):475–86. https://doi.org/10.2217/epi.15.4 PMID: 26077432.
4. Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi A. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell deathc. Genes Dev. 1995; 1(9):15–30.
5. Singh P, Ravanan P, Talwar P. Death Associated Protein Kinase 1 (DAPK1): A Regulator of Apoptosis and Autophagy. Frontiers in molecular neuroscience. 2016; 9:46. https://doi.org/10.3389/fnmol.2016. 00046 PMID: 27445685. Epub 2016/07/23. Eng.
6. Celik S, Akcora D, Ozkan T, Varol N, Aydos S, Sunguroglu A. Methylation analysis of the DAPK1 gene in imatinib-resistant chronic myeloid leukemia patients. Oncology letters. 2015 Jan; 9(1):399–404. https://doi.org/10.3892/ol.2014.2677 PMID: 25435999. Epub 2014/12/02. Eng.
7. Schneider-Stock R. Death-associated kinase (DAPK): a cancer "gene chameleon". Apoptosis: an international journal on programmed cell death. 2014 Feb; 19(2):285. https://doi.org/10.1007/s10495-013-0932-5 PMID: 24198143. Epub 2013/11/08. Eng.
8. Ye M, Li D, Zhou F, Guo Q, Xia B. Epigenetic regulation of death-associated protein kinase expression in primary gastric cancers from Chinese patients. European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP). 2012 May; 21(3):241–6. https://doi.org/10.1097/CEJ.0b013e32834c9caa PMID: 21979297. Epub 2011/10/08. Eng.
9. Mittag F, Kuester D, Vieth M, Peters B, Stolte B, Roessner A, et al. DAPK promotor methylation is an early event in colorectal carcinogenesis. Cancer letters. 2006 Aug 18; 240(1):69–75. https://doi.org/10.1016/j.canlet.2005.08.034 PMID: 16246486. Epub 2005/10/26. Eng.
10. Kuester D, Dar AA, Moskaluk CC, Krueger S, Meyer F, Hartig R, et al. Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett’s esophageal adenocarcinoma and its association with clinical progression. 2007 Mar; 9(3):236–45. PMID: 17401463. Epub 2007/04/03. Eng.
11. Nomura T, Tahara T, Shiroeda H, Minato T, Matsue Y, Hayashi R, et al. Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium. BMC gastroenterology. 2013 Jan 2; 13:1. https://doi.org/10.1186/1471-230X-13-1 PMID: 23280118. Epub 2013/01/ 03. Eng.
12. Lee BB, Lee EJ, Jung EH, Chun HK, Chang DK, Song SY, et al. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2009 Oct 1; 15(19):6185–91. https://doi.org/10.1158/1078-0432.CCR-09-0111 PMID: 19773381. Epub 2009/09/24. Eng.
13. Xu XL, Yu J, Zhang HY, Sun MH, Gu J, Du X, et al. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World journal of gastroenterology. 2004 Dec 1; 10(23):3441–54. https://doi.org/10.3748/wjg.v10.i23.3441 PMID: 15526363. Epub 2004/11/05. Eng.
14. Waki T, Tamura G, Sato M, Terashima M, Nishizuka S, Motoyama T. Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer science. 2003 Apr; 94(4):360–4. PMID: 12824905. Epub 2003/06/26. Eng.
15. Xiong J, Li Y, Huang K, Lu M, Shi H, Ma L, et al. Association between DAPK1 promoter methylation and cervical cancer: a meta-analysis. PloS one. 2014; 9(9):e107272. https://doi.org/10.1371/journal.pone. 0107272 PMID: 25268905. Epub 2014/10/01. Eng.
16. Chen J, Xia Q, Jiang B, Chang W, Yuan W, Ma Z, et al. Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis. PloS one. 2015; 10(12):e0145164. https://doi.org/10.1371/journal.pone.0145164 PMID: 26682730.
17. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in medicine. 2002 Jun 15; 21(11):1539–58. https://doi.org/10.1002/sim.1186 PMID: 12111919.
18. Bagci B, Sari M, Karadayi K, Turan M, Ozdemir O, Bagci G. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients. Cancer biomarkers: section A of Disease markers. 2016 Jun 24; 17(2):133–43. https://doi.org/10.3233/CBM-160624 PMID: 27540971. Epub 2016/08/20. Eng.
19. Laskar RS, Ghosh SK, Talukdar FR. Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics. Molecular carcinogenesis. 2015 Dec; 54(12):1786–95. https://doi.org/10.1002/mc.22250 PMID: 25418895. Epub 2014/11/25. Eng.
20. Almeida FG, de Aquino PF, de Souza AD, de Souza AQ, do Carmo Vinhote S, Mac-Cormick TM, et al. Colorectal cancer DNA methylation patterns from patients in Manaus, Brazil. Biological research. 2015 Sep 12; 48:50. https://doi.org/10.1186/s40659-015-0042-7 PMID: 26363785. Epub 2015/09/14. Eng.
21. Kupcinskaite-Noreikiene R, Skieceviciene J, Jonaitis L, Ugenskiene R, Kupcinskas J, Markelis R, et al. CpG island methylation of the MLH1, MGMT, DAPK, and CASP8 genes in cancerous and adjacent noncancerous stomach tissues. Medicina (Kaunas, Lithuania). 2013; 49(8):361–6. PMID: 24509146. Epub 2014/02/11. Eng.
22. Li B, Wang B, Niu LJ, Jiang L, Qiu CC. Hypermethylation of multiple tumor-related genes associated with DNMT3b up-regulation served as a biomarker for early diagnosis of esophageal squamous cell carcinoma. Epigenetics. 2011 Mar; 6(3):307–16. https://doi.org/10.4161/epi.6.3.14182 PMID: 21150312. Epub 2010/12/15. Eng.
23. Hu SL, Kong XY, Cheng ZD, Sun YB, Shen G, Xu WP, et al. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma. Tumori. 2010 Sep-Oct; 96(5):726–33. PMID: 21302620. Epub 2011/02/10. Eng.
24. Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Human pathology. 2009 Nov; 40(11): 1534–42. https://doi.org/10.1016/j.humpath.2009.01.029 PMID: 19695681. Epub 2009/08/22. Eng.
25. Ksiaa F, Ziadi S, Amara K, Korbi S, Trimeche M. Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinoma. Clinica chimica acta; international journal of clinical chemistry. 2009 Jun 27; 404(2):128–33. https://doi.org/10.1016/j.cca.2009.03.044 PMID: 19336228. Epub 2009/04/02. Eng.
26. Kato K, Iida S, Uetake H, Takagi Y, Yamashita T, Inokuchi M, et al. Methylated TMS1 and DAPK genes predict prognosis and response to chemotherapy in gastric cancer. International journal of cancer. 2008 Feb 1; 122(3):603–8. https://doi.org/10.1002/ijc.23143 PMID: 17943730. Epub 2007/10/19. Eng.
27. Anacleto C, Leopoldino AM, Rossi B, Soares FA, Lopes A, Rocha JC, et al. Colorectal cancer "methylator phenotype": fact or artifact? Neoplasia (New York, NY). 2005 Apr; 7(4):331–5. PMID: 15967110. Epub 2005/06/22. Eng.
28. Chan AW, Chan MW, Lee TL, Ng EK, Leung WK, Lau JY, et al. Promoter hypermethylation of Death-associated protein-kinase gene associated with advance stage gastric cancer. Oncology reports. 2005 May; 13(5):937–41. PMID: 15809761. Epub 2005/04/06. Eng.
29. Schildhaus HU, Krockel I, Lippert H, Malfertheiner P, Roessner A, Schneider-Stock R. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach. International journal of oncology. 2005 Jun; 26(6):1493–500. PMID: 15870861. Epub 2005/05/05. Eng.
30. Lee S, Hwang KS, Lee HJ, Kim JS, Kang GH. Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Laboratory investigation; a journal of technical methods and pathology. 2004 Jul; 84(7):884–93. https://doi.org/10.1038/labinvest.3700108 PMID: 15122305. Epub 2004/05/04. Eng.
31. Sabbioni S, Miotto E, Veronese A, Sattin E, Gramantieri L, Bolondi L, et al. Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood. Molecular diagnosis: a journal devoted to the understanding of human disease through the clinical application of molecular biology. 2003; 7(3–4):201–7. PMID: 15068392. Epub 2004/04/08. Eng.
32. Yamaguchi S, Asao T, Nakamura J, Ide M, Kuwano H. High frequency of DAP-kinase gene promoter methylation in colorectal cancer specimens and its identification in serum. Cancer letters. 2003 May 8; 194(1):99–105. PMID: 12706863. Epub 2003/04/23. Eng.
33. To KF, Leung WK, Lee TL, Yu J, Tong JH, Chan MW, et al. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. International journal of cancer. 2002 Dec 20; 102(6):623–8. https://doi.org/10.1002/ijc.10783 PMID: 12448005. Epub 2002/11/ 26. Eng.
34. Ogino S, Nishihara R, VanderWeele TJ, Wang M, Nishi A, Lochhead P, et al. The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-Neoplastic Diseases in the Era of Precision Medicine. Epidemiology. 2016; 27(4):602–11. https://doi.org/10.1097/EDE.0000000000000471 PMID: 26928707
35. Ogino S, Chan AT, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut. 2010; 60(3):397–411. https://doi.org/10.1136/gut.2010.217182 PMID: 21036793
36. Hughes LAE, Melotte V, de Schrijver J, de Maat M, Smit VTHBM, Bovee JVMG, et al. The CpG Island Methylator Phenotype: What’s in a Name? Cancer research. 2013; 73(19):5858–68. https://doi.org/10.1158/0008-5472.CAN-12-4306 PMID: 23801749
37. Harden SV, Tokumaru Y, Westra WH, Goodman S, Ahrendt SA, Yang SC, et al. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Clinical cancer research: an official journal of the American Association for Cancer Research. 2003 Apr; 9(4):1370–5. PMID: 12684406. Epub 2003/04/10. Eng.
38. Catto JW, Azzouzi AR, Rehman I, Feeley KM, Cross SS, Amira N, et al. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2005 May 1; 23(13):2903–10. https://doi.org/10.1200/JCO.2005.03.163 PMID: 15753461. Epub 2005/03/09. Eng.
39. Zhai J, Yang X, Zhang Y, Qi Q, Hu J, Wang Q. Reduced expression levels of the death-associated protein kinase and E-cadherin are correlated with the development of esophageal squamous cell carcinoma. Experimental and therapeutic medicine. 2013 Mar; 5(3):972–6. PMID: 23408147. Epub 2013/02/ 15. Eng.
40. Stevens C, Lin Y, Harrison B, Burch L, Ridgway RA, Sansom O, et al. Peptide combinatorial libraries identify TSC2 as a death-associated protein kinase (DAPK) death domain-binding protein and reveal a stimulatory role for DAPK in mTORC1 signaling. The Journal of biological chemistry. 2009 Jan 2; 284(1):334–44. https://doi.org/10.1074/jbc.M805165200 PMID: 18974095. Epub 2008/11/01. Eng.
41. Qin Y, Ye GX, Wu CJ, Wang S, Pan DB, Jiang JY, et al. Effect of DAPK1 gene on proliferation, migration, and invasion of carcinoma of pancreas BxPC-3 cell line. International journal of clinical and experimental pathology. 2014; 7(11):7536–44. PMID: 25550789. Epub 2015/01/01. Eng.
42. Zhao J, Zhao D, Poage GM, Mazumdar A, Zhang Y, Hill JL, et al. Death-associated protein kinase 1 promotes growth of p53-mutant cancers. The Journal of clinical investigation. 2015 Jul 1; 125(7): 2707–20. https://doi.org/10.1172/JCI70805 PMID: 26075823. Epub 2015/06/16. Eng.
43. Sanchez-Cespedes M, Esteller M, Wu L, Nawroz-Danish H, Yoo GH, Koch WM, et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer research. 2000 Feb 15; 60(4):892–5. PMID: 10706101. Epub 2000/03/08. Eng.
44. Hu S, Liu D, Tufano RP, Carson KA, Rosenbaum E, Cohen Y, et al. Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer. International journal of cancer. 2006 Nov 15; 119(10):2322–9. https://doi.org/10.1002/ijc.22110 PMID: 16858683. Epub 2006/07/22. Eng.
45. Gonzalez-Gomez P, Bello MJ, Alonso ME, Lomas J, Arjona D, Aminoso C, et al. Frequent death-associated protein-kinase promoter hypermethylation in brain metastases of solid tumors. Oncology reports. 2003 Jul-Aug; 10(4):1031–3. PMID: 12792765. Epub 2003/06/07. Eng.
46. Agodi A, Barchitta M, Quattrocchi A, Maugeri A, Vinciguerra M. DAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis. PloS one. 2015; 10(8):e0135078. https://doi.org/10.1371/journal.pone.0135078 PMID: 26267895. Epub 2015/08/13. Eng.
47. Li Y, Zhu M, Zhang X, Cheng D, Ma X. Clinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis. Drug design, development and therapy. 2015; 9:1785–96. https://doi.org/10.2147/DDDT.S78012 PMID: 25848215. Epub 2015/04/08. Eng.
48. Jia W, Yu T, Cao X, An Q, Yang H. Clinical effect of DAPK promoter methylation in gastric cancer. Medicine. 2016; 95(43):e5040. https://doi.org/10.1097/MD.0000000000005040 PMID: 27787359
49. Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, et al. Increased number of CpG island hypermethylation in tumor suppressor genes of non-neoplastic gastric mucosa correlates with higher risk of gastric cancer. Digestion. 2010; 82(1):27–36. https://doi.org/10.1159/000252766 PMID: 20150736. Epub 2010/02/13. Eng.
50. Qu Y, Dang S, Hou P. Gene methylation in gastric cancer. Clinica chimica acta; international journal of clinical chemistry. 2013 Sep 23; 424:53–65. https://doi.org/10.1016/j.cca.2013.05.002 PMID: 23669186. Epub 2013/05/15. Eng.
51. Brock MV, Gou M, Akiyama Y, Muller A, Wu TT, Montgomery E, et al. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clinical cancer research: an official journal of the American Association for Cancer Research. 2003 Aug 1; 9(8):2912–9. PMID: 12912936. Epub 2003/08/13. Eng.
52. Fackler MJ, McVeigh M, Mehrotra J, Blum MA, Lange J, Lapides A, et al. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer research. 2004 Jul 1; 64(13):4442–52. https://doi.org/10.1158/0008-5472.CAN-03-3341 PMID: 15231653.